September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...
September 17, 2019
September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the ...
September 12, 2019
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...
September 12, 2019
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...
September 11, 2019
September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 11, 2019
September 10,2019 — The combination of ticagrelor and aspirin reduces ischemic events compared with aspirin alone in ...
September 10, 2019
September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major ...
September 10, 2019
September 9, 2019 — Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary ...
September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...
September 09, 2019
September 9, 2019 — More than 33,000 health professionals gathered over five days to attend the 2019 European Society of ...
September 09, 2019
September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...
September 09, 2019
Feature | Magnetic Resonance Imaging (MRI) | Jeff Zagoudis, Associate Editor
Traditionally, computed tomography (CT) and ultrasound have been the workhorse imaging modalities in the world of ...
September 06, 2019
September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...
September 05, 2019
September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...
September 05, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now